Is the use of greater than 1 L of intravenous crystalloids associated with worse outcomes in trauma patients?
Adolescent
Adult
Aged
Aged, 80 and over
Crystalloid Solutions
/ administration & dosage
Erythrocyte Transfusion
Female
Hospital Mortality
Humans
Infusions, Intravenous
Injury Severity Score
Length of Stay
/ statistics & numerical data
Male
Middle Aged
Nevada
Registries
Resuscitation
/ methods
Retrospective Studies
Trauma Centers
Treatment Outcome
Crystalloids
Resuscitation
Trauma
Journal
The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
11
11
2020
revised:
05
12
2020
accepted:
05
12
2020
pubmed:
20
12
2020
medline:
24
2
2021
entrez:
19
12
2020
Statut:
ppublish
Résumé
Advanced Trauma Life Support guidelines recommend only 1 L of intravenous (IV) crystalloid before transitioning to blood products. We sought to determine if receiving >1 L of IV crystalloid during the initial resuscitation is associated with worse outcomes. We also sought to determine if receiving no crystalloids is associated with better outcomes. We performed a single center retrospective study using trauma registry data, which was supplemented by manual chart review. We only included patients who had an initial heart rate ≥ 100 beats/min or a systolic blood pressure ≤ 90 mmHg. For each patient, we determined the total amount of IV crystalloid administered in the first 3 h after arrival to the hospital plus prehospital crystalloid. We performed multivariate regression analyses to determine if there is an association between the administration of >1 L of crystalloids or no crystalloids with in-hospital mortality, hospital length of stay (LOS), or packed red blood cells (PRBCs) transfused. Between January 1, 2018 and September 30, 2019, there were 878 who met criteria for enrollment. Among those, 55.0% received ≤1 L of IV crystalloids, and 45.0% received >1 L. Multivariate analyses showed no significant association between receiving >1 L and mortality (p = 0.61) or PRBCs transfused (p = 0.29), but patients who received >1 L had longer hospital LOS (p = 0.04). We found no association between receiving no crystalloids and mortality, PRBCs transfused, or LOS. On a multivariate analysis of trauma patients, we did not find an association between the administration of >1 L of IV crystalloid and in-hospital mortality or the volume of PRBCs transfused. However, receiving >1 L of crystalloids was associated with a longer hospital LOS. We found no benefit to completely withholding crystalloids.
Identifiants
pubmed: 33340875
pii: S0735-6757(20)31130-X
doi: 10.1016/j.ajem.2020.12.013
pii:
doi:
Substances chimiques
Crystalloid Solutions
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
32-36Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest We have no conflicts of interest to report.